Want to see CHE full AI Analyst Report?
CHE Stock Chart & Stats
$384.61
$3.45(0.65%)
At close: 4:00 PM EST
$384.61
$3.45(0.65%)
Day’s Range― - ―
52-Week Range$365.21 - $497.25
Previous CloseN/A
Volume12.19K
Average Volume (3M)201.45K
Market Cap
$6.53B
Enterprise Value$5.40K
Total Cash (Recent Filing)$16.86M
Total Debt (Recent Filing)$236.93M
Price to Earnings (P/E)26.8
Beta0.26
Next Earnings
Jul 28, 2026EPS Estimate
5.6Next Dividend Ex-DateN/A
Dividend Yield0.51%
Share Statistics
EPS (TTM)18.39
Shares Outstanding13,274,104
10 Day Avg. Volume147,046
30 Day Avg. Volume201,454
Financial Highlights & Ratios
PEG Ratio-2.78
Price to Book (P/B)6.29
Price to Sales (P/S)2.43
P/FCF Ratio18.93
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$473.00Price Target Upside22.98% Upside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)24.34
Revenue Forecast (FY)$2.69B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationChemed’s substantial operating cash flow and high free cash flow conversion (FCF/net income ~0.84 TTM) provide durable internal funding for reinvestment, franchise repurchases, dividends and debt service. Strong cash conversion supports capital allocation flexibility and resilience to cyclical or reimbursement shocks over multiple quarters.
Conservative Balance SheetThe company’s low leverage gives lasting financial flexibility to fund VITAS growth, absorb reimbursement or regulatory shifts, and pursue accretive M&A or franchise buybacks. Conservative capital structure reduces refinancing risk and preserves optionality across the intermediate term.
VITAS-driven Revenue And Guidance UpgradeImproving VITAS admissions, higher average revenue per day, and upward revision to ADC and revenue guidance indicate durable demand and operational leverage in hospice services. Given the payor-backed revenue model, stronger census and per‑day revenue support predictable cash flows and sustained margin improvement over coming quarters.
Bears Say
Roto‑Rooter Margin DeteriorationA meaningful YoY EBITDA and margin decline at Roto‑Rooter reflects structural profitability pressure from mix, pricing and operational issues. If these headwinds persist, they will compress consolidated margins and reduce free cash flow growth unless offset by efficiency gains or sustained pricing recovery.
Persistent Elevated Marketing CostsHigher and ongoing paid-lead acquisition costs raise customer acquisition costs across Roto‑Rooter, compress margin on incremental revenue and lengthen payback on franchise investments. Over several quarters, persistent elevated marketing spend can materially reduce segment operating leverage and returns on growth initiatives.
Shorter VITAS Length Of StayA sizable drop in average length of stay shifts mix toward shorter stays, lowering revenue per admission and demanding higher admission volumes to sustain topline. Over the medium term this mix change can pressure margins, increase sensitivity to referral flows, and make revenue more volatile versus prior stay patterns.
Chemed News
CHE FAQ
What was Chemed’s price range in the past 12 months?
Chemed lowest stock price was $365.20 and its highest was $497.25 in the past 12 months.
What is Chemed’s market cap?
Chemed’s market cap is $6.53B.
When is Chemed’s upcoming earnings report date?
Chemed’s upcoming earnings report date is Jul 28, 2026 which is in 11 days.
How were Chemed’s earnings last quarter?
Chemed released its earnings results on Apr 23, 2026. The company reported $5.65 earnings per share for the quarter, beating the consensus estimate of $5.302 by $0.348.
Is Chemed overvalued?
According to Wall Street analysts Chemed’s price is currently Undervalued.
Does Chemed pay dividends?
Chemed pays a Quarterly dividend of $0.6 which represents an annual dividend yield of 0.51%. See more information on Chemed dividends here
What is Chemed’s EPS estimate?
Chemed’s EPS estimate is 5.6.
How many shares outstanding does Chemed have?
Chemed has 13,274,104 shares outstanding.
What happened to Chemed’s price movement after its last earnings report?
Chemed reported an EPS of $5.65 in its last earnings report, beating expectations of $5.302. Following the earnings report the stock price went up 9.959%.
Which hedge fund is a major shareholder of Chemed?
Currently, no hedge funds are holding shares in CHE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Chemed Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$473.00 (22.98% Upside)
$473.00 (22.98% Upside)
Blogger Sentiment
Bullish
CHE Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 14.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 4.0%
Last 30 Days ▼ 4.0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.37%
12-Months-Change
Fundamentals
Return on Equity
25.33%
Trailing 12-Months
Asset Growth
-11.05%
Trailing 12-Months
Company Description
Chemed
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
CHE Stock 12 Month Forecast
Average Price Target
$473.00
▲(22.98% Upside)
Technical Analysis
Ownership Overview
1.25% Insiders
30.78% Mutual Funds
0.27% Other Institutional Investors
37.87% Public Companies and
Individual Investors